drugset

drugset / Trial / NCT00076531

Clinical Trial for Prostate Cancer

NCT00076531 ↗

Phase 3 Completed Oakwood Laboratories, LLC

Open-labelTreatment

Summary

Phase III trial using an injectable for treatment of prostate cancer.

Timeline

Start: 2003-12
Primary completion: 2004-11
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Leuprolide	Other / unclassified	22.5 mg	—

Indications